Portfolio: Biotechnology

Oxagen Limited
Small molecule drugs for inflammatory and respiratory diseases

Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies

Peplin Limited
Development and commercialisation of prescription therapeutic products for cancer patients

Peptimmune, Inc.
Immunotherapeutics for autoimmune disorders

Pharmasset, Inc.
Exited via the public markets

Pharmathene, Inc.
Biotherapeutics targeting bioterrorism